Sanyou Biopharmaceuticals is a high-tech biopharmaceutical company driven by the mission of “To make it easy to develop new drugs worldwide”. Guided by the vision “To become a front-runner in global innovative drug R&D”, the company focuses on the R&D and commercialization of innovative drugs.

With AI-STAL, our world-leading AI- powered super-trillion antibody library, as our source of innovation and SAI-DA, our intelligent drug-discovery accelerator integrating dry-lab (in silico) and wet-lab work, as our core engine, we are building Clicklinks, an open innovation system. Driven by new drug pipelines, we accelerate the translation of innovation to benefit broad patient populations.